Companies: 10,795·Total market cap: $144.5T
Natera, Inc.

Natera, Inc.

NTRANASDAQHealthcare● Active
$213.47
$-1.84(-0.85%)
Market Cap$30.6B
P/E Ratio
52W High$256.36
52W Low$131.811

Natera, Inc. (NTRA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ntra · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Natera, Inc. (NTRA) measures how much investors pay for each dollar of the company's trailing earnings. NTRA's current PE ratio of N/A is calculated by dividing its stock price of $213.47 by its TTM earnings per share of -$1.60.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.33
Based on 10 analysts
EPS (TTM)
-$1.60
TTM · diluted EPS
PEG Ratio
4.43
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Natera, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2012 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Natera, Inc.
Natera, Inc.You
NTRA
$30.6BN/A-$1.60
BioNTech SE
BioNTech SE
BNTX
$21.6BN/A-$4.51
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
$21.8B19.42x-28.9%$8.94
DexCom, Inc.
DexCom, Inc.
DXCM
$29.6B30.97x+13.5%$2.14
Illumina, Inc.
Illumina, Inc.
ILMN
$23.9B24.52x-10.1%$5.48
IQVIA Holdings Inc.
IQVIA Holdings Inc.
IQV
$30.7B28.49x+4.4%$7.91
Mettler-Toledo International Inc.
Mettler-Toledo International Inc.
MTD
$23.0B33.06x+21.1%$42.17
Industry Average
5 peers with valid PE
27.29xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 14 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.52
2024-12-31
FY2024
$-1.53
2023-12-31
FY2023
$-3.78
2022-12-31
FY2022
$-5.57
2021-12-31
FY2021
$-5.21
2020-12-31
FY2020
$-2.84
2019-12-31
FY2019
$-1.79
2018-12-31
FY2018
$-2.22
2017-12-31
FY2017
$-2.56
2016-12-31
FY2016
$-1.86

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Natera, Inc. (NTRA) measures how much investors pay for each dollar of the company's trailing earnings. NTRA's current PE ratio of N/A is calculated by dividing its stock price of $213.47 by its TTM earnings per share of -$1.60.

PE Ratio = Stock Price ÷ EPS (TTM)
= $213.47 ÷ -$1.60 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NTRA pe ratio · 6 questions

NTRA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $213.47 and TTM EPS of -$1.60. Data sourced from Financial Modeling Prep via NTRA's SEC 10-K and 10-Q filings.

NTRA PE ratioWhat is NTRA PE ratioCurrent PE ratio of NTRANTRA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Natera, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08